Chen, B., Chen, X., Lv, H., Guo, Y., Han, X., Zhang, G., Zhao, J., Xu, W., Nie, C., Wang, J., He, Y., Chen, X. (2026). Fruquintinib in combination with sintilimab and CAPEOX as first-line treatment for advanced gastric/gastroesophageal junction adenocarcinoma: A single-arm, open-label, multicenter phase Ib/II study (FUNCTION).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e16033